THC: Tenet Healthcare Corporation Stock

by  •  • Comments Off on THC: Tenet Healthcare Corporation Stock

SIC 8062 – General Medical and Surgical Hospitals

Valuation
Market Cap ($M) 9,706.38
Enterprise Value ($M) 27,380.38
Book Value ($M) 5,508.00
Book Value / Share 55.53
Price / Book 1.76
NCAV ($M) -15,637.00
NCAV / Share -157.65
Price / NCAV -0.62

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.13

Liquidity (mrq)
Quick Ratio 1.42
Current Ratio 1.51

Balance Sheet (mrq) ($M)
Current Assets 7,167.00
Assets 28,312.00
Liabilities 22,804.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 20,548.00
Operating Income 2,427.00
Net Income 611.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,374.00
Cash from Investing -969.00
Cash from Financing -1,035.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-15 13G Lind Global Fund II LP 9.90
02-14 13G Price T Rowe Associates Inc /md/ 7.00
02-14 13G/A Harris Associates L P 0.00 -99.93
02-14 13G/A Glenview Capital Management, Llc 7.62 -12.97
02-13 13G/A Vanguard Group Inc 10.94 -1.71
02-09 13G Invesco Ltd. 5.30 29.82
02-02 13G/A BlackRock Inc. 10.70 -5.36

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 OR ¨ Transition report pursuant to Sect
2023-10-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 OR ¨ Transition report pursuan
2023-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023 OR ¨ Transition report pursuant to
2023-04-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023 OR ¨ Transition report pursuant to

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 126,275 617,185 20.46
2024-04-23 173,556 1,111,030 15.62
2024-04-22 197,641 1,139,860 17.34
2024-04-19 205,027 1,127,374 18.19

(click for more detail)

Similar Companies
HCA – HCA Healthcare, Inc. MD – Pediatrix Medical Group, Inc.
SEM – Select Medical Holdings Corporation


Financial data and stock pages provided by
Fintel.io